BIO-key International, Inc. (BKYI): Price and Financial Metrics


BIO-key International, Inc. (BKYI): $1.00

0.03 (+2.83%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BKYI Stock Summary

  • BIO KEY INTERNATIONAL INC's market capitalization of $8,592,189 is ahead of only 2.5% of US-listed equities.
  • For BKYI, its debt to operating expenses ratio is greater than that reported by only 11.91% of US equities we're observing.
  • With a year-over-year growth in debt of 117.68%, BIO KEY INTERNATIONAL INC's debt growth rate surpasses 89.44% of about US stocks.
  • Stocks that are quantitatively similar to BKYI, based on their financial statements, market capitalization, and price volatility, are TACT, SOFO, FLUX, HTGM, and OSPN.
  • Visit BKYI's SEC page to see the company's official filings. To visit the company's web site, go to www.bio-key.com.

BKYI Valuation Summary

  • BKYI's price/sales ratio is 1.4; this is 16.67% higher than that of the median Industrials stock.
  • Over the past 243 months, BKYI's price/sales ratio has gone down 45.9.

Below are key valuation metrics over time for BKYI.

Stock Date P/S P/B P/E EV/EBIT
BKYI 2022-11-25 1.4 0.8 -1.2 -0.9
BKYI 2022-11-23 1.5 0.8 -1.2 -0.9
BKYI 2022-11-22 1.5 0.8 -1.3 -1.0
BKYI 2022-11-21 1.4 0.8 -1.2 -0.9
BKYI 2022-11-18 1.4 0.8 -1.2 -0.9
BKYI 2022-11-17 1.4 0.8 -1.2 -0.9

BKYI Growth Metrics

    Its 3 year cash and equivalents growth rate is now at 1163.01%.
  • The year over year revenue growth rate now stands at 22.94%.
  • Its 5 year revenue growth rate is now at -24.78%.
BKYI's revenue has moved up $609,403 over the prior 52 months.

The table below shows BKYI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 6.196767 -6.198709 -7.269158
2022-06-30 6.122047 -6.023397 -5.771027
2022-03-31 5.167022 -7.214244 -5.213753
2021-12-31 5.114489 -8.978428 -5.065781
2021-09-30 5.243387 -8.372161 -4.474205
2021-06-30 4.887883 -8.222945 -6.74411

BKYI Price Target

For more insight on analysts targets of BKYI, see our BKYI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.00 Average Broker Recommendation 1.5 (Moderate Buy)

BKYI Stock Price Chart Interactive Chart >

Price chart for BKYI

BKYI Price/Volume Stats

Current price $1.00 52-week high $2.90
Prev. close $0.97 52-week low $0.92
Day low $0.93 Volume 12,400
Day high $1.00 Avg. volume 36,271
50-day MA $1.42 Dividend yield N/A
200-day MA $1.82 Market Cap 8.45M

BIO-key International, Inc. (BKYI) Company Bio


BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. It offers ID Director, a solution for integration with CA Technologies / Broadcom's Single Sign-on solution, Oracle's Fusion Middleware SSO, IBM Tivoli Access Manager, as well as ISAM and other solutions. The company also provides Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities into their respective product offerings or infrastructure; Intelligent Image Indexing, a biometric identification solution that offers one-to-many and one-to-one user identification; and Biometric Service Provider, which provides support for the BioAPI for a compliant interface to applications using biometrics for verification and identification. In addition, it offers WEB-key, an authentication-transaction security technology to conduct identification and identity verification transactions in unsecure environments, such as the world wide Web or off-site cloud environments. Additionally, the company develops and distributes hardware components; and sells third-party hardware components. BIO-key International, Inc. markets its products through its sales force, as well as through distributors, resellers, integrators, value added resellers, and technology partners. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.


BKYI Latest News Stream


Event/Time News Detail
Loading, please wait...

BKYI Latest Social Stream


Loading social stream, please wait...

View Full BKYI Social Stream

Latest BKYI News From Around the Web

Below are the latest news stories about BIO KEY INTERNATIONAL INC that investors may wish to consider to help them evaluate BKYI as an investment opportunity.

Passwordless Is All The Rage — But There Are Considerations To Be Made

By Gita Karunakaran, Benzinga

Yahoo | November 15, 2022

Cyber-Security Provider BIO-key Reports Q3 and Year-to-Date Revenues Rose to $1.4M and $5.3M, Respectively, on Growing Software and Services Revenue; Investor Call Tomorrow at 10am ET

WALL, N.J., Nov. 14, 2022 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring Identity-Bound Biometrics (IBB), today reported results for its third quarter ended September 30, 2022 (Q3’22). BIO-key will host an investor call tomorrow at 10:00 a.m. ET (details below). Q3 Highlights: Q3’22 revenues rose 6% to $1.4M vs. Q3’21 and year-to-date revenues incr

Yahoo | November 14, 2022

BIO-key’s Integrated Solution Could Help Provide A Cost-Effective Cyber Insurance Solution

By Gita Karunakaran, Benzinga

Yahoo | November 9, 2022

CORRECTION -- BIO-key, Provider of Identity Access Management (IAM) and Biometric Cybersecurity Solutions, Hosts Q3 Investor Call Tues, November 15th at 10am ET

WALL, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by BIO-key International, Inc. (NASDAQ: BKYI), please note that the Audio Replay code has been updated to 8070313. The corrected release follows: BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring Identity-Bound Biometrics (IBB), will review its Q3 results in a conferenc

Yahoo | November 7, 2022

BIO-key, Provider of Identity Access Management (IAM) and Biometric Cybersecurity Solutions, Hosts Q3 Investor Call Tues, November 15th at 10am ET

WALL, N.J., Nov. 07, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) and large-scale identity solutions, featuring Identity-Bound Biometrics (IBB), will review its Q3 results in a conference call on Tuesday, November 15th at 10 a.m. after releasing results pre-market. Members of the management team including Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will participate on the call

Yahoo | November 7, 2022

Read More 'BKYI' Stories Here

BKYI Price Returns

1-mo -38.27%
3-mo -40.83%
6-mo -44.75%
1-year -56.71%
3-year -77.27%
5-year -91.07%
YTD -54.75%
2021 -37.22%
2020 -12.00%
2019 -33.33%
2018 -57.63%
2017 -33.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9659 seconds.